|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/32 | |
| A61K 39/395 | |||
| A61K 31/395 | |||
| A61P 13/08 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2788380 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12813984.7 |
| Europos patento paraiškos padavimo data | 2012-12-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/056949 |
| Data | 2012-12-04 |
| (87) | Numeris | WO 2013/084147 |
| Data | 2013-06-13 |
| (30) | Numeris | Data | Šalis |
| 201161566890 P | 2011-12-05 | US |
| (72) |
ELIS, Winfried, DE
ETTENBERG, Seth, US
GARNER, Andrew Paul, US
HAUBST, Nicole, DE
HUANG, Xizhong, US
KUNZ, Christian Carsten Silvester, DE
REISINGER SPRAGUE, Elizabeth Anne, US
SHENG, Qing, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |
| ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) |